نتایج جستجو برای: age related macular degeneration convolutional neural

تعداد نتایج: 2089624  

Journal: :International Ophthalmology Clinics 2015

Journal: :Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition 2011
Judith Pijnacker Peter Verstraten Wim van Damme Jo Vandermeulen Bert Steenbergen

Macular degeneration (MD) is the most common cause of visual impairment among older adults. It severely affects reading performance. People with MD have to rely on peripheral vision for reading. In this review, we considered several training programs that aim to improve peripheral reading, with a focus on eccentric viewing, oculomotor control, or perceptual learning. There was no strong support...

Journal: :Journal of current glaucoma practice 2013
George Kampougeris Dimitrios Spyropoulos Adrianna Mitropoulou

Intraocular pressure (IOP) rise after anti-vascular endothelial growth factor (VEGF) treatment for neovascular age-related macular degeneration (AMD) can be either short-term or long-term and may require medical intervention. Short-term IOP spikes are a fairly common and well recognized complication of anti-VEGF injections. Long-term IOP rise is less well-understood and disputed as a complicati...

Journal: :Journal of immunology 2011
Nadine Lauer Michael Mihlan Andrea Hartmann Ursula Schlötzer-Schrehardt Claudia Keilhauer Hendrik P N Scholl Peter Charbel Issa Frank Holz Bernhard H F Weber Christine Skerka Peter F Zipfel

Age-related macular degeneration is a leading form of blindness in Western countries and is associated with a common SNP (rs 1061170/Y402H) in the Factor H gene, which encodes the two complement inhibitors Factor H and FHL1. However, the functional consequences of this Tyr(402) His exchange in domain 7 are not precisely defined. In this study, we show that the Tyr(402) His sequence variation af...

2012
Jaclyn L. Kovach Stephen G. Schwartz Harry W. Flynn Ingrid U. Scott

Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید